1. Home
  2. PAYO vs CHEK Comparison

PAYO vs CHEK Comparison

Compare PAYO & CHEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PAYO
  • CHEK
  • Stock Information
  • Founded
  • PAYO 2005
  • CHEK 2004
  • Country
  • PAYO United States
  • CHEK Israel
  • Employees
  • PAYO N/A
  • CHEK N/A
  • Industry
  • PAYO EDP Services
  • CHEK Medical Electronics
  • Sector
  • PAYO Technology
  • CHEK Health Care
  • Exchange
  • PAYO Nasdaq
  • CHEK Nasdaq
  • Market Cap
  • PAYO N/A
  • CHEK 4.5M
  • IPO Year
  • PAYO N/A
  • CHEK 2015
  • Fundamental
  • Price
  • PAYO $7.44
  • CHEK $0.85
  • Analyst Decision
  • PAYO Strong Buy
  • CHEK
  • Analyst Count
  • PAYO 7
  • CHEK 0
  • Target Price
  • PAYO $12.79
  • CHEK N/A
  • AVG Volume (30 Days)
  • PAYO 3.2M
  • CHEK 52.9K
  • Earning Date
  • PAYO 05-07-2025
  • CHEK 05-14-2025
  • Dividend Yield
  • PAYO N/A
  • CHEK N/A
  • EPS Growth
  • PAYO 29.17
  • CHEK N/A
  • EPS
  • PAYO 0.31
  • CHEK N/A
  • Revenue
  • PAYO $977,716,000.00
  • CHEK N/A
  • Revenue This Year
  • PAYO $9.23
  • CHEK N/A
  • Revenue Next Year
  • PAYO $11.14
  • CHEK N/A
  • P/E Ratio
  • PAYO $23.73
  • CHEK N/A
  • Revenue Growth
  • PAYO 17.64
  • CHEK N/A
  • 52 Week Low
  • PAYO $4.69
  • CHEK $0.56
  • 52 Week High
  • PAYO $11.29
  • CHEK $3.04
  • Technical
  • Relative Strength Index (RSI)
  • PAYO 35.43
  • CHEK 51.99
  • Support Level
  • PAYO $6.98
  • CHEK $0.77
  • Resistance Level
  • PAYO $7.97
  • CHEK $0.93
  • Average True Range (ATR)
  • PAYO 0.24
  • CHEK 0.08
  • MACD
  • PAYO 0.08
  • CHEK 0.01
  • Stochastic Oscillator
  • PAYO 32.35
  • CHEK 67.02

About CHEK Check-Cap Ltd.

Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but it currently expects to market products in the United States, Europe, Israel and Japan.

Share on Social Networks: